COMMUNIQUÉS West-GlobeNewswire

Hydropothecary renforce son équipe de direction en vue de la légalisation du cannabis à fins récréatives

13/03/2018 - 13:17

GATINEAU, Québec, 13 mars 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (TSX CROISSANCE:THCX) (« Hydropothecary ») a le plaisir d’annoncer l’arrivée de trois nouveaux cadres dans son équipe de direction. Roch [...]

Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Returns to Uptick Newswire's "Stock Day" Podcast with Everett Jolly to Review Significant Achievements in 2017 and Discuss Exciting Developments Expected in 2018

13/03/2018 - 13:08

Phoenix, March 13, 2018 (GLOBE NEWSWIRE) -- Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly [...]

Avid Bioservices to Participate at Upcoming CDMO Industry Conferences

13/03/2018 - 13:05

TUSTIN, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]

Genedrive PLC: Commercial sales of Genedrive® HCV ID Kit and platform begin

13/03/2018 - 13:01

13 March 2018 genedrive plc ("genedrive" or the "Company") Commercial sales of Genedrive® HCV ID Kit and platform begin Decentralised molecular HCV assays shipped to Africa genedrive plc (AIM: GDR), the near patient [...]

Healthwise and GetWellNetwork Partner to Deliver Award-Winning Health Education

13/03/2018 - 13:00

BOISE, Idaho, March 13, 2018 (GLOBE NEWSWIRE) -- Healthwise and GetWellNetwork ® announced today they will partner in offering health education to health care providers and their patients. GetWellNetwork will add over [...]

CrownBio Enters Strategic Partnership with Phanes Therapeutics to Accelerate Discovery and Development of Phanes’ Novel Oncology Agents

13/03/2018 - 13:00

SAN DIEGO, March 13, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]

Tauriga Sciences Inc. Purchases Shares of Virginia Based NASDAQ Listed Company Focused on Nuclear Fuel Technology Development

13/03/2018 - 13:00

NEW YORK, NY , March 13, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]

Caladrius Biosciences Doses First Patient with CLBS12 in Phase 2 Critical Limb Ischemia Trial in Japan

13/03/2018 - 13:00

BASKING RIDGE, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]

Rexahn Pharmaceuticals to Present at Two Upcoming Conferences

13/03/2018 - 13:00

B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (CHIPS) on March 16 Oppenheimer 28th Annual Healthcare Conference on March 21 ROCKVILLE, Md., March 13, 2018 (GLOBE NEWSWIRE) -- Rexahn [...]

Biotricity Appoints Casey Shattuck as New VP of Sales to Spearhead Bioflux Launch

13/03/2018 - 13:00

REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]

MannKind Announces STAT Study Results Accepted for Presentation at American Diabetes Association’s 78th Scientific Sessions

13/03/2018 - 13:00

WESTLAKE VILLAGE, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ) focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]

Avinger Provides Update on U.S. Intellectual Property Portfolio

13/03/2018 - 13:00

REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced three recent additions to its U.S [...]

RavenQuest Completes Final Tranche of Financing

13/03/2018 - 13:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, March [...]

AIT Therapeutics Announces Year End 2017 Financial Results Conference Call and Webcast

13/03/2018 - 13:00

Call Scheduled for Monday, March 19, 2018 at 4:30pm Eastern Time. NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled [...]

Annual General Meeting 2018 – GN Store Nord A/S

13/03/2018 - 12:48

Today, GN Store Nord A/S held its annual general meeting in accordance with the agenda announced on February 19, 2018. The report by the board of directors was adopted, and both the Annual Report 2017 and the proposal [...]

Checkpoint Therapeutics to Participate in March Investor Conferences

13/03/2018 - 12:45

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]

Mustang Bio to Present at March Investor Conferences

13/03/2018 - 12:45

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]

Fortress Biotech to Present at Oppenheimer’s 28th Annual Healthcare Conference

13/03/2018 - 12:45

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO ) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]

Fluidigm Announces Exchange of Convertible Notes

13/03/2018 - 12:45

SOUTH SAN FRANCISCO, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that it has entered into separate privately negotiated transactions to exchange approximately $25.0 [...]